INSTITUT PASTEUR DE LILLE
66Patents
38Active
66Granted
47Portfolio score
Filing activity: Jul 7, 1987 → Apr 14, 2020 · 9 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8658153B2 | Bifidobacterial species | Chemistry; Metallurgy | 71 | Active |
| US5871746A | Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines | Chemistry; Metallurgy | 36 | Expired |
| US7476386B1 | Mixed lipopeptide micelles for inducing an immune response | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6841358B1 | RECOMBINANT PROTEINS OF FILAMENTOUS HAEMAGGLUTININ OF BORDETELLA, PARTICULARLY BORDETELLA PERTUSSIS, METHOD FOR PRODUCING SAME, AND USES THEREOF FOR PRODUCING FOREIGN PROTEINS OF VACCINATING ACTIVE PRINCIPLES | Chemistry; Metallurgy | 24 | Expired |
| US5993823A | Cytotoxic T lymphocyte-inducing lipopeptides and methods of use | Chemistry; Metallurgy | 12 | Expired |
| US6291175A | Methods for treating a neurological disease by determining BCHE genotype | Chemistry; Metallurgy | 12 | Expired |
| US7833699B2 | Detection of tuberculosis and infection by Mycobacterium tuberculosis using HBHA | Physics | 10 | Active |
| US5021560A | Immunogenic fraction active against bilharzioses, its preparation, and immunizing compositions containing it | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6683052B1 | Lipopeptides containing an interferon-&ggr; fragment, and uses thereof in pharmaceutical compositions | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6015564A | Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines | Chemistry; Metallurgy | 8 | Expired |
| US6723526B1 | Composition for forming a dried lens-shaped pellet comprising albumin, starch, microorganisms and sugar and/or salt | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5942392A | Genetic markers used jointly for the diagnosis of Alzheimer's disease, and diagnostic method and kit | Emerging Cross-Sectional Technologies | 6 | Expired |
| US9655959B2 | Adenylate cyclase deficient bordetella strains | Human Necessities | 6 | Active |
| US9528086B2 | Recombinant bordetella strains | Emerging Cross-Sectional Technologies | 6 | Active |
| US9415077B2 | Effect of an attenuated Bordetella strain against allergic disease | Human Necessities | 5 | Active |
| US6660261B1 | Bordetella strain expressing the FHA hybrid, liposomes and vaccines | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5824788A | Cloning of gene encoding the GP28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications | Chemistry; Metallurgy | 4 | Expired |
| US6670328B1 | Proteins and peptides derived from protein ESM-1 and their uses in the treatment and diagnosis of diseases linked to leukocyte migration | Human Necessities | 4 | Expired |
| US10682377B2 | Mutant Bordetella strains and methods of use | Human Necessities | 4 | Active |
| US9119804B2 | Live attenuated bordetella strains as a single dose vaccine against whooping cough | Emerging Cross-Sectional Technologies | 4 | Active |
| US8338599B2 | Compounds having a potentiating effect on the activity of ethionamide and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US6949345B1 | Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin | Physics | 3 | Expired |
| US6818219B1 | Reagent for detecting and monitoring viral infections | Physics | 3 | Expired |
| US7390875B2 | Method for binding, in solution, a peptide and a lipophilic vector and uses thereof | Human Necessities | 2 | Expired |
| US9796758B2 | Native ligation process | Emerging Cross-Sectional Technologies | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.